Recent News

'Good' bacteria is possible solution for unchecked inflammation in bowel diseases

'Good' bacteria is possible solution for unchecked inflammation in bowel diseases

In a study published in journal Nature Immunology, researchers led by UNC Lineberger member Jenny P.Y. Ting, PhD, described how inflammation can go unchecked in the absence of a certain inflammation inhibitor called NLRP12. In a harmful feedback loop, this inflammation can upset the balance of bacteria living in the gut. Beneficial bacteria may be the key to reversing inflammation in the absence of this key regulator.

'Good' bacteria is possible solution for unchecked inflammation in bowel diseases - Read More…

Earp, Ting recognized for career achievements in cancer research

Earp, Ting recognized for career achievements in cancer research

UNC Lineberger's H. Shelton Earp, MD, director of UNC Cancer Care and the Lineberger Professor of Cancer Research, and Jenny P.Y. Ting, PhD, the William Rand Kenan Professor of Genetics, have been honored with the Hyman L. Battle Distinguished Cancer Research Award.

Earp, Ting recognized for career achievements in cancer research - Read More…

UNC Lineberger launches innovative cellular immunotherapy program

UNC Lineberger launches innovative cellular immunotherapy program

UNC Lineberger, with its U.S. FDA-approved Good Manufacturing Practices, or “clean,” facility, is one of only a select academic centers in the United States with the capability to genetically modify patient immune cells for clinical use. This makes it possible for people who live in the Southeastern U.S. to stay closer to home to undergo cellular immunotherapy treatment.

UNC Lineberger launches innovative cellular immunotherapy program - Read More…

Spring deadline is March 15 for cancer research grant proposals

Spring deadline is March 15 for cancer research grant proposals

There are two categories of awards offered this spring for the UNC Lineberger Developmental Funding Award: Pilot Awards of up to $50,000 for one-year projects involving one principal investigator, and Stimulus Awards of up to $100,000 per year for one or two years for projects that enhance our scientific understanding of cancer basic mechanisms or clinical and public health practice.

Spring deadline is March 15 for cancer research grant proposals - Read More…